1. Home
  2. DNOW vs NRIX Comparison

DNOW vs NRIX Comparison

Compare DNOW & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NOW Inc.

DNOW

NOW Inc.

HOLD

Current Price

$14.23

Market Cap

2.5B

Sector

Industrials

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$23.64

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNOW
NRIX
Founded
1862
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.5B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
DNOW
NRIX
Price
$14.23
$23.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
12
Target Price
$16.67
$30.50
AVG Volume (30 Days)
3.0M
1.9M
Earning Date
05-07-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,648,000,000.00
$76,987,000.00
Revenue This Year
$69.47
N/A
Revenue Next Year
$8.01
$48.05
P/E Ratio
N/A
N/A
Revenue Growth
25.68
99.31
52 Week Low
$10.94
$8.20
52 Week High
$17.26
$25.09

Technical Indicators

Market Signals
Indicator
DNOW
NRIX
Relative Strength Index (RSI) 66.95 62.87
Support Level $13.73 $14.63
Resistance Level $14.31 $24.98
Average True Range (ATR) 0.36 1.22
MACD 0.14 -0.27
Stochastic Oscillator 98.08 62.00

Price Performance

Historical Comparison
DNOW
NRIX

About DNOW NOW Inc.

Dnow Inc is a provider of energy and industrial solutions and a distributor of pipe, valves, and fittings (PVF) and pumps, as well as fabrication, assembly, and testing of process and production equipment. It provides a broad mix of products required to build and maintain essential infrastructure and operating equipment across upstream, midstream, gas utilities, downstream, energy transition, and industrial markets, along with value-added supply chain solutions and technical product expertise supported by digital offerings through its DigitalNOW and MRCGO e-commerce platforms. The company operates mainly under the DNOW and MRC brands and has three reportable segments: the United States, which generates the majority of revenue, Canada, and International.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: